Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatrice Coornaert

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biochemical and Biophysical Research Communications|August 2, 2008
Smurf2 is a TRAF2 binding protein that triggers TNF-R2 ubiquitination and TNF-R2-induced JNK activationIsabelle Carpentier, Beatrice Coornaert, Rudi Beyaert
The Journal of Biological Chemistry|November 15, 2008
A20: central gatekeeper in inflammation and immunityBeatrice Coornaert, Isabelle Carpentier, Rudi Beyaert
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulationKelly Verhelst, Lynn Verstrepen, Beatrice Coornaert, et al.
Materials Today. Bio|May 9, 2025
Novel high throughput 3D ECM remodeling assay identifies MEK as key driver of fibrotic fibroblast activityChen-Yi Liao, Jasmijn H M Hundscheid, Justin Crawford, et al.
Nature Immunology|January 29, 2008
T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20Beatrice Coornaert, Mathijs Baens, Karen Heyninck, et al.
Biomedicines|June 26, 2025
Improved Translational Relevance of In Vitro Fibrosis Models by Integrating IOX2-Mediated Hypoxia-Mimicking PathwaysManuel A González Hernández, Jennifer Venhorst, Lars Verschuren, et al.
Scientific Reports|October 7, 2024
Identifying patient subgroups in MASLD and MASH-associated fibrosis: molecular profiles and implications for drug developmentManuel A González Hernández, Lars Verschuren, Martien P M Caspers, et al.
The Journal of Biological Chemistry|December 10, 2009
Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intoleranceBéatrice Bailly-Maitre, Bengt F Belgardt, Sabine D Jordan, et al.
Journal of Medicinal Chemistry|May 3, 2021
Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary FibrosisOscar Mammoliti, Adeline Palisse, Caroline Joannesse, et al.
Journal of Medicinal Chemistry|September 28, 2021
Discovery and Optimization of Orally Bioavailable Phthalazone and Cinnolone Carboxylic Acid Derivatives as S1P2 Antagonists against Fibrotic DiseasesOscar Mammoliti, Koen Jansen, Sandy El Bkassiny, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|August 2, 2008
Smurf2 is a TRAF2 binding protein that triggers TNF-R2 ubiquitination and TNF-R2-induced JNK activationIsabelle Carpentier, Beatrice Coornaert, Rudi Beyaert
The Journal of Biological Chemistry|November 15, 2008
A20: central gatekeeper in inflammation and immunityBeatrice Coornaert, Isabelle Carpentier, Rudi Beyaert
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulationKelly Verhelst, Lynn Verstrepen, Beatrice Coornaert, et al.
Materials Today. Bio|May 9, 2025
Novel high throughput 3D ECM remodeling assay identifies MEK as key driver of fibrotic fibroblast activityChen-Yi Liao, Jasmijn H M Hundscheid, Justin Crawford, et al.
Nature Immunology|January 29, 2008
T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20Beatrice Coornaert, Mathijs Baens, Karen Heyninck, et al.
Biomedicines|June 26, 2025
Improved Translational Relevance of In Vitro Fibrosis Models by Integrating IOX2-Mediated Hypoxia-Mimicking PathwaysManuel A González Hernández, Jennifer Venhorst, Lars Verschuren, et al.
Scientific Reports|October 7, 2024
Identifying patient subgroups in MASLD and MASH-associated fibrosis: molecular profiles and implications for drug developmentManuel A González Hernández, Lars Verschuren, Martien P M Caspers, et al.
The Journal of Biological Chemistry|December 10, 2009
Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intoleranceBéatrice Bailly-Maitre, Bengt F Belgardt, Sabine D Jordan, et al.
Journal of Medicinal Chemistry|May 3, 2021
Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary FibrosisOscar Mammoliti, Adeline Palisse, Caroline Joannesse, et al.
Journal of Medicinal Chemistry|September 28, 2021
Discovery and Optimization of Orally Bioavailable Phthalazone and Cinnolone Carboxylic Acid Derivatives as S1P2 Antagonists against Fibrotic DiseasesOscar Mammoliti, Koen Jansen, Sandy El Bkassiny, et al.
Pageof 1